Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas

被引:77
作者
Hui, AM [1 ]
Kanai, Y [1 ]
Sakamoto, M [1 ]
Tsuda, H [1 ]
Hirohashi, S [1 ]
机构
[1] NATL CANC CTR,RES INST,DIV PATHOL,CHUO KU,TOKYO 104,JAPAN
关键词
D O I
10.1002/hep.510250314
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
p21(WAF1/CIP1) is a universal cyclin-dependent kinase (cdk) inhibitor, the expression of which is regulated by p53-dependent and p53-independent pathways. We examined p21(WAF1/CIP1) expression in and p53 status of 21 primary hepatocellular carcinomas (HCCs) by reverse-transcriptase polymerase chain reaction (RT-PCR) and by PCR single-strand conformation polymorphism (PCR-SSCP) analysis. p21(WAF1/CIP1) messenger RNA expression was reduced markedly in 8 of 21 HCCs (38.1%) and 5 of these 8 HCCs bore p53 mutations. The relative p21(WAF1/CIP1) messenger RNA expression value of HCCs with p53 mutations (.73 +/- .13 U, n = 6) was significantly lower than that of HCCs with wild-type p53 (1.00 +/- 0.21 U, n = 14; P < .01). The p21(WAF1/CIP1) expression levels in cancerous tissues (.73 +/- .13 U) were significantly reduced in comparison with those in noncancerous tissues (.97 +/- .13 U) (P < .01) in the 6 cases with p53 mutations. These data indicate that p21(WAF1/CIP1) expression in HCCs is predominantly regulated by dependence on p53 and that reduced p21(WAF1/CIP1) expression may participate in hepatocarcinogenesis.
引用
收藏
页码:575 / 579
页数:5
相关论文
共 41 条
[1]   GENERAL METHOD FOR ISOLATION OF HIGH MOLECULAR-WEIGHT DNA FROM EUKARYOTES [J].
BLIN, N ;
STAFFORD, DW .
NUCLEIC ACIDS RESEARCH, 1976, 3 (09) :2303-2308
[2]   LOSS OF HETEROZYGOSITY SUGGESTS TUMOR SUPPRESSOR GENE RESPONSIBLE FOR PRIMARY HEPATOCELLULAR-CARCINOMA [J].
BUETOW, KH ;
MURRAY, JC ;
ISRAEL, JL ;
LONDON, WT ;
SMITH, M ;
KEW, M ;
BLANQUET, V ;
BRECHOT, C ;
REDEKER, A ;
GOVINDARAJAH, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8852-8856
[3]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[4]  
DIGIUSEPPE JA, 1995, AM J PATHOL, V147, P884
[5]  
ELDEIRY WS, 1994, CANCER RES, V54, P1169
[6]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[7]  
EMI M, 1992, CANCER RES, V52, P5368
[8]   ALLELIC LOSS AT CHROMOSOME BAND 8P21.3-P22 IS ASSOCIATED WITH PROGRESSION OF HEPATOCELLULAR-CARCINOMA [J].
EMI, M ;
FUJIWARA, Y ;
OHATA, H ;
TSUDA, H ;
HIROHASHI, S ;
KOIKE, M ;
MIYAKI, M ;
MONDEN, M ;
NAKAMURA, Y .
GENES CHROMOSOMES & CANCER, 1993, 7 (03) :152-157
[9]  
HARPER JW, 1993, CELL, V75, P805
[10]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53